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In Brief
Moreno-Vicente et al. report that CAV1, a
key component of PM mechanosensing
caveolae, mediates adaptation to ECM
rigidity by modulating YAP activity
through the control of actin dynamics and
phosphorylation-dependent interaction
of YAP with the 14-3-3-domain protein
YWHAH. Cav1-dependent YAP regulation
drives two pathophysiological processes:
ECM remodeling and pancreatic ADM.
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The transcriptional regulator YAP orchestrates many
cellular functions, including tissue homeostasis,
organ growth control, and tumorigenesis. Mechani-
cal stimuli are a key input to YAP activity, but the
mechanisms controlling this regulation remain
largely uncharacterized. We show that CAV1 posi-
tively modulates the YAP mechanoresponse to sub-
strate stiffness through actin-cytoskeleton-depen-
dent and Hippo-kinase-independent mechanisms.
RHO activity is necessary, but not sufficient, for
CAV1-dependent mechanoregulation of YAP activ-
ity. Systematic quantitative interactomic studies
and image-based small interfering RNA (siRNA)
screens provide evidence that this actin-dependent
regulation is determined by YAP interaction with
the 14-3-3 protein YWHAH. Constitutive YAP acti-
vation rescued phenotypes associated with CAV1
loss, including defective extracellular matrix (ECM)
remodeling. CAV1-mediated control of YAP activity
was validated in vivo in a model of pancreatitis-
driven acinar-to-ductal metaplasia. We propose
that this CAV1-YAP mechanotransduction system
controls a significant share of cell programs linked
to these two pivotal regulators, with potentially broad
physiological and pathological implications.INTRODUCTION
The integral membrane protein Caveolin-1 (CAV1) engages in
crosstalk with the actin cytoskeleton and connects directly to
actin cables through the protein FLNA (Muriel et al., 2011; Stahl-
hut and van Deurs, 2000). CAV1 controls focal adhesion stability,
actin organization, and actomyosin contraction through RHO
GTPases (Echarri et al., 2007; Goetz et al., 2011; Grande-Garcı´a1622 Cell Reports 25, 1622–1635, November 6, 2018 ª 2018 The Au
This is an open access article under the CC BY license (http://creativeet al., 2007) and contributes to mechanosensing and adaptation
in response to various mechanical stimuli, such as membrane
stretching, shear stress, hypoosmotic shock, and cell detach-
ment (Boyd et al., 2003; Muriel et al., 2011; Sinha et al., 2011).
However, current understanding remains limited regarding the
mechanisms by which these phenomena are integrated with
overall cell function.
The transcriptional cofactor yes-associated protein (YAP)
operates downstream of the canonical Hippo pathway (Piccolo
et al., 2014), a highly conserved pathway regulating organ
growth control, tissue homeostasis, and tumorigenesis (Yu
et al., 2015). YAP regulates the transcription of specific gene
sets mainly through its interaction with TEA domain (TEAD) tran-
scription factors (Zhao et al., 2008). A cascade of kinases,
including LATS1 and LATS2, lead to YAP phosphorylation and
curb its nucleocytoplasmic shuttling, mediating its cytosolic
retention through interaction with 14-3-3 proteins, thus downre-
gulating YAP transcriptional output (Dong et al., 2007; Hao et al.,
2008; Zhao et al., 2007). This regulatory network is controlled by
upstream cues related to tissue architecture and cellular context,
such as cell-cell adhesion, cell density, and cell polarity (Piccolo
et al., 2014). YAP is also controlled by mechanical signals, such
as extracellular matrix (ECM) stiffness, shear stress, and stretch-
ing (Codelia et al., 2014; Dupont et al., 2011; Zhong et al., 2013).
Stiff environments favor YAP nuclear localization (i.e., activation),
whereas attachment to soft substrates increases cytoplasmic
retention. This mechanical control, which determines cell prolif-
eration and differentiation (Dupont et al., 2011), depends on RHO
GTPase function and actomyosin-driven contractility but is
largely independent of kinase regulation, because (1) depletion
of LATS1/2 kinases does not alter the mechanical responsive-
ness of YAP and (2) non-phosphorylatable mutants are nonethe-
less sensitive to substrate stiffness (Dupont et al., 2011; Elose-
gui-Artola et al., 2017). The adaptation of nuclear pore units to
mechanical tension also contributes to the regulation of YAP nu-
clear entry (Elosegui-Artola et al., 2017). However, understand-
ing is limited about the exact molecular mechanisms by which
ECM stiffness controls YAP activity. Here, we identify CAV1 as
an upstream positive regulator of YAP that affects the responsethors.
commons.org/licenses/by/4.0/).
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to changes in ECM stiffness through amechanism dependent on
F-actin dynamics.
The mechanical regulation of YAP underpins pathophysiolog-
ical processes such as cardiovascular disease, inflammation
and tissue regeneration, and cancer (Panciera et al., 2017).
YAP activation by ECM stiffness promotes cancer-associated
fibroblast activation and subsequent peritumoral ECM remodel-
ing and stiffening, establishing a positive-feedback loop that fa-
vors cancer progression (Calvo et al., 2013). Here, we show that
overexpression of constitutively active YAP mutants rescues the
blunted contractility and ECM remodeling previously reported
for Cav1 genetic deficiency (Goetz et al., 2011). The positive
impact of YAP activity on tumor initiation and progression
is further showcased by its critical contribution to pancreatitis-
induced acinar-to-ductal metaplasia (ADM), which favors
pancreatic ductal carcinoma (PDAC) initiation (Gruber et al.,
2016).We further demonstrate CAV1-dependent positive regula-
tion of YAP in vivo, showing that Cav1-knockout (Cav1KO)
pancreatic parenchyma fails to upregulate YAP in response to
induced pancreatitis and exhibits blunting of changes associ-
ated with YAP activation, such as ADM.
Our results provide important insight into the mechanisms
regulating YAP function. We identify CAV1 as an upstream regu-
lator of YAP, controlling its transcriptional activity through the
control of actin cytoskeleton dynamics. Conversely, YAP under-
pins an important share of CAV1-dependent phenotypes. We
propose this CAV1-YAP regulation has important implications
in the progression of some pathologies, such as cancer, and
will allow us to better understand the principles governing pro-
cesses driven by substrate stiffness in health and disease.
RESULTS
CAV1 Positively Regulates YAP Activity by Controlling
YAP Nucleocytoplasmic Shuttling
ECM stiffness mediates CAV1 internalization (Du et al., 2011).
We confirmed that CAV1 was internalized in cells grown on
soft substrates (Figure S1A) and trafficked to a RAB11-positiveFigure 1. CAV1 Modulates YAP Activity
(A) Variations in gene expression in the RNA-seq analysis between cells grown on
genes alone (right bar). Genes significantly upregulated by ECM stiffness are boxe
test. Genes highlighted green are those that were upregulated on the stiff substr
(B) qRT-PCR analysis ofCtgf and Ankrd1 expression inWT and Cav1KOMEFs gro
on a stiff substrate. n = 3.
(C) TEAD transcriptional activity in WT and Cav1KO MEFs expressing the 8xGTII
activity was measured and normalized as described in STAR Methods. Data are
(D) Confocal immunofluorescence images of YAP expression in WT and Cav1KO
conjugated phalloidin (red; left column), and nuclei were stainedwith Hoechst (blue
YAP ROI (boxed in white in the YAP images).
(E) Percentage of cells from analysis as in (D) with predominantly nuclear YAP (N)
(N/C). Randomly selected images from 3 independent experiments were analyze
(F) SEEK computational gene co-expression analysis, showing expression corre
(G) Confocal immunofluorescence images of YAP in WT and Cav1KO MEFs plate
spread to a predefined size of 2,025 mm2 or 300 mm2. Nuclear contours are outlin
(H) ImageJ quantification of YAP subcellular distribution in cells plated on micropa
as the nuclear to total cell staining intensities; 10–20 cells were analyzed from 2
quartiles, and 90th and 10th percentiles (whiskers).
(I) qRT-PCR analysis of the YAP targets Ctgf and Ankrd1 in cells subjected to cycl
Data in (B), (C), (E), and (I) are presented as means ± SEM; *p < 0.05, **p < 0.01,
1624 Cell Reports 25, 1622–1635, November 6, 2018recycling endosome (Figure S1B). Thus, cell detachment from
integrin-ECM-mediated adhesions and cell growth on soft sub-
strates both trigger the same translocation of CAV1 from the
plasma membrane toward a recycling endosome (del Pozo
et al., 2005; Muriel et al., 2011). These observations suggest
that CAV1 could mediate the response to changes in substrate
rigidity. To evaluate the potential contribution of CAV1 to ECM
stiffness mechanotransduction, we performed RNA sequencing
(RNA-seq) in wild-type (WT) and Cav1KO mouse embryonic fi-
broblasts (MEFs) cultured on rigid or compliant polyacrylamide
hydrogels (GEO: GSE120514). Using Ingenuity Pathway Analysis
(IPA) software and the Enrichr open-source tool (Chen et al.,
2013; Kuleshov et al., 2016), we queried our datasets for canon-
ical functional programs and Gene Ontology terms responsive to
substrate rigidity, classifying them according to their specificity
for WT or Cav1KO backgrounds (Figures S1C and S1D). This
analysis identified a stiffness-induced increase in genes related
to the regulation of actin cytoskeleton, focal adhesions, and
cell junctions exclusively in WT cells.
To explore the molecular mechanisms mediating this effect
of CAV1 on gene expression, we focused on YAP because this
transcriptional cofactor is a prominent transcriptional driver
of genes involved in cell adhesion and actin cytoskeleton organi-
zation (Stein et al., 2015) and is also positively regulated by
mechanical cues such as ECM stiffness (Dupont et al., 2011).
To assess whether YAP function was controlled by substrate
stiffness in our system, we first analyzed the expression of a
panel of 61 genes previously characterized as YAP targets in
MCF10A and NIH 3T3 cells (Dupont et al., 2011; Zhao et al.,
2008). A Fisher exact test confirmed statistically significant upre-
gulation of endogenous YAP targets by ECM stiffness in WT
cells, but not in Cav1KO cells (Figure 1A). This finding was sup-
ported by qRT-PCR analysis of the YAP targets Ankrd1 and Ctgf
(Figure 1B) and by orthogonal assays to monitor TEAD activity
(Figure 1C) based on the 8xGTIIC luciferase reporter (Dupont
et al., 2011). To explore the mechanism of this CAV1 depen-
dency, we first studied YAP subcellular distribution (Figure 1D),
which was classified as cytosolic (C), nuclear (N), or evenlystiff and soft substrates, showing all identified genes (left bar) and YAP-target
d, and the enrichment for YAP target geneswas analyzed using the Fisher exact
ate, whereas those highlighted red were downregulated.
wn on stiff and soft substrates for 24 hr. Data are normalized toWT cells grown
C-luciferase reporter and grown on stiff or soft substrates for 24 hr. Luciferase
normalized to WT MEFs grown on stiff substrate. n = 4.
MEFs grown on stiff or soft substrate. F-actin was stained with fluorophore-
inmerged images; third column). The right column shows zoomed views of the
, predominantly cytosolic YAP (C), or an even nuclear-to-cytosolic distribution
d (60–200 interphase cells per condition).
lation (Z score) between YAP target genes and the rest of the genome.
d on different micropatterns with a fibronectin-coated grid that allows cells to
ed with dotted gray lines.
tterns of 3 grid sizes (300 mm2, 1,024 mm2, and 2,025 mm2). Data are presented
biological replicates per condition. The boxplots show the median, 1st and 3rd
ic mechanical stretching (CS; see STARMethods) and unstretched cells. n = 4.
***p < 0.005, and ****p < 0.0005. See also Figure S1 and Table S1.
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Figure 2. Hippo-Kinase-Independent YAP Serine Phosphorylation Determines Impaired Nuclear Translocation and Blunted YAP-Dependent
Transcriptional Activity in Cav1KO Cells
(A) Western blot of Ser112-phopshorylated YAP and total YAP in WT and Cav1KO MEFs and Cav1KO MEFs reconstituted with CAV1 (o_CAV1) or IRES-GFP.
(B) Confocal immunofluorescence of cells transfected with YAP-FLAG or YAP(S5A)-FLAG and stained with anti-FLAG antibody (green), fluorophore-conjugated
phalloidin (red), and Hoechst (blue).
(C) FLAG distribution from analysis as in (B), represented as the ratio of nuclear-to-cytosolic intensities. n = 6–11.
(D) Western blot analysis of FLAG subcellular distribution in MEFs transfected with YAP-FLAG or YAP(S5A)-FLAG followed by biochemical fractionation.
RHO-GDI and Tef-1 were used as cytosolic and nuclear markers, respectively. The percentage of total YAP located in the nuclear fractions was quantified (right
graph).
(legend continued on next page)
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distributed (N/C) (Figure 1E). As expected, YAP was predomi-
nantly nuclear in WT cells plated on stiff substrate and retained
in the cytosol in cells plated on soft substrate. However, in
Cav1KO MEFs, YAP was predominantly retained in the cyto-
plasm independently of substrate rigidity and compliance.
Defective YAP nuclear localization in Cav1KO cells was
confirmed by biochemical fractionation (Figure S1E). These re-
sults indicate that the positive regulation of YAP transcriptional
activity by environmental rigidity is CAV1 dependent.
To rule out a cell-specific effect on YAP-CAV1 functional inter-
actions, we used small interfering RNA (siRNA) duplexes to tran-
siently knock down CAV1 in epithelial MDA-MB-231 human
breast carcinoma cells. CAV1 silencing significantly decreased
Ctgf and Ankrd1 expression (Figure S1G). Moreover, qRT-PCR
profiling of immortalized neonatal mouse hepatocytes revealed
a similar reduction in YAP target gene expression in cells har-
vested from Cav1KO mice compared with those from WT mice
(Figure S1H). To further assess the robustness of the CAV1-
YAP interaction, we used the SEEK open-access resource
(Zhu et al., 2015) to query known YAP target genes for coexpres-
sion patterns against the whole genome across extensive data-
sets from different tissues and cell lines (Figure 1F; Table S1).
Cav1, whose mRNA levels highly correlate with its protein
expression (Sonntag et al., 2014), showed one of the highest
expression correlations with our YAP target list query (0.4994).
These observations were upheld by the analysis of an indepen-
dent dataset, generated by assessing the correlation between
the expression of Cav1 and the rest of the genome across 300
cell lines (Pellinen et al., 2018); in this analysis, 79%of YAP target
genes correlated positively with Cav1 expression and 11%
correlated negatively (Figure S1G). Together, these observations
suggest that CAV1-dependent regulation of YAP transcriptional
activity is a general mechanism operating across different exper-
imental systems.
Simultaneous siRNA-mediated knockdown of YAP and TAZ,
to prevent potential compensatory mechanisms, effectively
blocked expression of the canonical targets Ctgf and Ankrd1 in
WT MEFs (Figures S1J and S1K). Consistent with a pivotal role
for CAV1 in the positive regulation of YAP, YAP/TAZ silencing
in Cav1KO cells did not further decrease Ctgf, Ankrd1, and
Cyr61 expression. Notably, CAV1 absence did not alter total
YAP protein levels (Figure S1J), suggesting that the relationship
betweenCAV1 and YAP-dependent transcriptional programs re-
lies on CAV1-dependent regulatory mechanisms upstream of
YAP and not on the regulation of YAP protein expression.
Cell spreading modulates YAP activity such that YAP is pre-
dominantly nuclear in cells spread over large areas and cytosolic
in cells with limited spreading (Dupont et al., 2011). Moreover,
cell polarization and spreading in MEFs is controlled by CAV1
(Grande-Garcı´a et al., 2007). To rule out the possibility that
CAV1-dependent differences in YAP activity were secondary
to differential cell spreading, we cultured MEFs on printed fibro-(E) TEAD transcriptional activity in MEFs transfected with YAP-FLAG and YAP(S5A
to growth on the soft substrate in each experiment. n = 3 (E). The fold-change w
(F) qRT-PCR forCtgf andAnkrd1 expression inWT andCAV1 KOMEFs transfecte
(G) qRT-PCR for Ctgf and Ankrd1 expression in WT and CAV1 KO MEFs transfe
Data are presented as mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.005, and ****p
1626 Cell Reports 25, 1622–1635, November 6, 2018nectin micropatterns of fixed area and shape. As expected,
YAP was predominantly cytosolic in WT MEFs spreading over
small micropatterns, whereas growth on large micropatterns
promoted a marked nuclear accumulation. This regulation was
blunted in CAV1-deficient cells (Figures 1G and 1H). These
observations confirm that CAV1-dependent YAP modulation is
not an indirect consequence of changes in cell geometry.
To assess this relationship in the context of other mechanical
cues, we evaluated the role of CAV1 in cell stretching, another
established YAP-activating stimulus (Aragona et al., 2013; Code-
lia et al., 2014). Using a stretching device, we exposed cells to
uniaxial cyclic strain. Stretching induced significant increases
in Ctgf and Ankrd1 expression in WT MEFs, but not in Cav1KO
cells (Figure 1I), suggesting that CAV1 modulates YAP activity
in response to different stimuli.
CAV1-Dependent Regulation of YAP Is Independent of
Hippo Kinase
Weobserved that YAP phosphorylation at S112was increased in
Cav1KO MEFs, and this increase was partly blocked by exoge-
nous CAV1 expression (Figure 2A). Previous reports proposed
the existence of nuclear pools of S127-phosphorylated YAP in
human cells (Wada et al., 2011), but our biochemical partition as-
says suggested that the phosphorylated form of the mouse ho-
mologous residue S112 is largely excluded from the nucleus in
our cellular model (Figure S2A). YAP phosphorylation at serine
127 (S112 in mice) promotes the retention of this transcription
factor in the cytosol (Basu et al., 2003; Zhao et al., 2007). We
evaluated the involvement of YAP phosphorylation in CAV1-
dependent regulation ectopically expressing YAP-FLAG and
the non-phosphorylatable mutant YAP-5SA (Figure S2B). We
transiently transfected these constructs into WT and Cav1KO
MEFs and analyzed their subcellular distribution by both immu-
nofluorescence and subcellular fractionation (Figures 2B–2D).
In WT MEFs, FLAG-tagged WT YAP was predominantly nuclear
but was mostly retained in the cytosol in Cav1KO MEFs. How-
ever, FLAG-tagged YAP-5SA accumulated in the nucleus in
both WT and Cav1KO MEFs, suggesting that cytosolic retention
of YAP in Cav1KO MEFs is at least partially dependent on its
regulated phosphorylation. Constitutive nuclear translocation
of YAP-5SA proteins in Cav1KO MEFs correlated with the
rescue of its downstream transcriptional output. YAP-5SA nu-
clear accumulation in Cav1KO MEFs correlated with increased
canonical YAP-TEAD transcriptional activity, assessed by
8xGTICC-luciferase reporter assay (Figure 2E). In contrast,
whereas WT YAP enhanced TEAD activity in WT MEFs, it did
not in Cav1KOMEFs, consistent with the cytosolic sequestration
of WT YAP-FLAG and endogenous YAP in Cav1KO MEFs.
These resultswere confirmed by qRT-PCRanalysis (Figure S2C).
It is important to note that while the fold increase was higher
in Cav1KO cells, YAP-5SA overexpression in Cav1KO cells
did not reach the levels observed in WT cells, suggesting)-FLAG, measured by 8xGTICC-luciferase reporter assay. Data are normalized
ith respect to untransfected cells is indicated above the bars.
d with control or Lats1 and 2 siRNAs. Data are normalized toWT control. n = 10.
cted with control or NF2 siRNAs. Data are normalized to WT control. n = 4.
< 0.0005. See also Figure S2.
that phosphorylation-independent mechanisms could also be
involved. Our observations indicate that YAP serine phosphory-
lation has an impact on CAV1-dependent control of YAP locali-
zation and activity.
YAP serine phosphorylation can be mediated by the kinases
LATS1 and LATS2 (Zhao et al., 2007). Knockdown of LATS1/2
increased Ctgf and Ankrd1 mRNA expression and TEAD-driven
luciferase reporter activity in both WT and Cav1KO cells, with
comparable fold increases (Figures 2G, S2D, and S2E). To
further evaluate the implication of Hippo canonical kinases in
the differences observed between WT and Cav1KO cells, we
analyzed the role of neurofibromin 2 (NF2). NF2 silencing led to
an increase in Ctgf and Ankrd1 expression in WT cells, but not
in Cav1KO cells (Figures 2H and S2F), supporting the existence
of alternative regulation upon suppression of LATS1/2 kinase
activity by NF2 knockdown and precluding rescue of YAP
activity in Cav1KO cells. Taken together, these results suggest
that LATS1/2 kinases are not essential for CAV1-dependent
YAP activity regulation.
CAV1-Dependent Regulation of YAP Activity Is Exerted
through the Control of Actin Polymerization
Since F-actin and RHO are necessary for YAP nuclear transloca-
tion and transcriptional activity (Dupont et al., 2011), we next
checked whether changes in actin cytoskeleton and RHO
signaling could explain the altered YAP regulation in Cav1KO
MEFs. For the analysis of actin dynamics and architecture, WT
and Cav1KO MEFs were cultured on large fibronectin micropat-
terns to ensure the same spreading area for both genetic back-
grounds and thus exclude effects of spreading area on actin dy-
namics of cell-cell interaction, spreading, and cell shape (Figures
3A and 3B). Actin dynamics and architecture were also analyzed
in cells cultured on stiff substrates (Figure 3C). Actin fiber organi-
zation was inferred by anisotropy analysis of microscopy images
tomeasure thedegreeofdeparture fromahomogeneousdistribu-
tion toward an increasingly discrete intensity distribution (STAR
Methods). Confirming CAV1 as a regulator of actin cytoskeleton
organization, actin fibers were less organized in Cav1KO cells.
We assessed the potential contribution of actin dynamics
to CAV1-dependent YAP regulation by using the actin polymer-
ization inhibitor cytochalasin D (CytD) and jasplakinolide, an
enhancer of F-actin actin polymerization (Holzinger, 2009; Pren-
tki et al., 1979). CytD decreased stress fiber density (Figure S3A),
reducing YAP nuclear accumulation and YAP target transcription
throughput in WT cells to levels akin to those in Cav1KO cells
(Figures 3D and S3A; see also Figures S3D and 4F). Conversely,
jasplakinolide enhanced actin polymerization (Figures S3B
and S3C), restored YAP nuclear translocation in Cav1KO
MEFs to WT levels (Figures 3D and 3E; see also Figure S3D),
and increased YAP target gene expression in both WT and
Cav1KO cells (Figure 4F). A constitutively active DIAPH1 mutant
(mDia1DN3), capable of boosting actin polymerization rates
(Watanabe et al., 1999), significantly upregulated YAP target
expression in Cav1KO cells (Figure S3E). These data strongly
suggest that actin polymerization is a key component of the
YAP regulatory machinery in our system. Altered actin dynamics
in Cav1KO cells are the direct cause of the reduced YAP activity
observed in this genetic background.We next explored the contribution of RHO signaling to actin-
and CAV1-dependent regulation of YAP using Y27632, a well-
established inhibitor of the upstream kinase ROCK1/2. Exposure
to Y27632 strongly reduced YAP target gene expression in WT
cells, reproducing the effect of CytD (see Figure 3A); in contrast,
Y27632 had only modest effects in Cav1KO cells (Figure S3F).
Transient transfection with a constitutively active form of
RHOA (RHOV14) that rescues RHO activity in Cav1KO MEFs
(Goetz et al., 2011) further increasedCtgf andAnkrd1 expression
in WT cells but did not enhance YAP target gene expression in
Cav1KO cells (Figure S3F). Our observations thus suggest that
while RHO signaling is necessary for the CAV1-dependent
positive mechanoregulation of YAP activity, it is not sufficient,
since defective RHO cannot explain the deficient YAP activity
in Cav1KO cells.
Deficient YAP Activity in Cav1KO Cells Is Mediated by
YWHAH-YAP Interaction
To characterize the molecular mechanisms underpinning the ef-
fect of CAV1-dependent actin dynamics on YAP activity, we pro-
filed the YAP interactome by YAP immunoaffinity purification and
mass spectrometry (MS) of control and CytD-treated WT and
Cav1KO cells (Figure S5; Table S2). We identified several previ-
ously described YAP-interacting proteins: AMOTL2 (Zhao et al.,
2011), POLR2A (Gavva et al., 1997), TBX5 (Rosenbluh et al.,
2012), RUNX1 (Levy et al., 2008), 14-3-3 proteins, and known
members of the Hippo pathway interactome (RBM15, CORO1C,
DBN1, DOCK7, LIMA1, MTCL1, PKP4, RAD21, and SLMAP;
Couzens et al., 2013). Interestingly, only WT cells showed inter-
actions between YAP and nuclear pore and/or transport com-
plexes, presumably reflecting effective nuclear translocation
(Figure 4A). Conversely, both Cav1KO and CytD-treated cells
were enriched for interactions with 14-3-3 proteins, which are re-
ported to retain phosphorylated YAP in the cytosol (Dong et al.,
2007) (Figure 4B).
To assess the contribution to YAP regulation of each compo-
nent of these context-specific YAP interactomes, we carried out
an image-based RNAi focused screen by knocking down 89
identified YAP interactors and comparing YAP subcellular distri-
bution in Cav1KO and WT cells (STAR Methods; Figures 4C, 4D,
S4A–S4C, and S5). Setting a stringent threshold of jZqj > 2.5, we
identified hits specific to WT cells for 10 genes, whose knock-
down blunted YAP nuclear translocation (Figures 4D and 4E).
These included siRNA pools targeting most nuclear pore com-
ponents previously shown to selectively interact with YAP in
WT cells (NUP155, NUP98, and AHCTF). Conversely, 8 hits
were identified as specific to Cav1KO cells, and siRNA-mediated
depletion of these genes enhanced YAP nuclear translocation.
This second subset included two Cav1KO-specific YAP interac-
tors, the 14-3-3-domain proteins YWHAH and YWHAB (Figures
4D, 4E, and S4D). We confirmed by western blot that YWHAH
interacts preferentially with YAP in Cav1KO cells in CytD-treated
WT cells compared with control WT cells (Figure S4E).
Accordingly, efficient YWHAH siRNA-mediated depletion
partially rescued the expression of YAP targets in Cav1KO cells
and CytD-treated WT cells (Figures 4F, S4F, and S4G). Notably,
this rescue was not effective in cells grown on soft substrates,
indicating that additional mechanisms might be involved in thisCell Reports 25, 1622–1635, November 6, 2018 1627
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Figure 3. YAP Activity Defects in Cav1KO MEFs Are a Consequence of Defective Actin Polymerization
(A) Confocal immunofluorescence images showing actin distribution in cells plated on large squared micropatterns (2,025 mm2). Actin was detected by staining
with fluorophore-conjugated phalloidin.
(B and C) Quantification of actin-fiber anisotropy (fiber order/organization) in WT and Cav1KO MEFs growing on squared micropatterns (n = 7–10; B) or on a stiff
ECM (n = 3; C).
(D) ImageJ quantification of YAP subcellular distribution in cells treated for 24 hr with 1 mMCytD, 0.05 mM jasplakinolide (Jasplak), or DMSO. Data were obtained
from 3 to 8 independent experiments and are presented as means ± SD; *p < 0.05, ***p < 0.005, and ****p < 0.0005.
(E) Confocal immunofluorescence of YAP in cells grown for 24 hr in the presence of 0.05 mM jasplakinolide or DMSO. Nuclei were detected with Hoechst (blue).
(F) qRT-PCR of YAP target genes inMEFs treated for 24 hr with 1 mMCytD, 0.05 mM jasplakinolide, or DMSO (control). Data from jasplakinolide experiments (n = 5)
and CytD experiments (n = 3) were normalized to WT controls. Data represent means ± SEM; *p < 0.05.
See also Figure S3.
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regulation. Taken together, these unbiased approaches suggest
that CAV1 determines YAP activity through the control of actin
dynamics, via mechanisms involving inhibition of the interaction
between YAP and 14-3-3 proteins such as YWHAH (Figure 4G).
YAP Is aMajor Effector of ECMRemodelingDownstream
of CAV1
YAP and caveolins are involved in a number of pathophysiolog-
ical processes, such as liver regeneration, muscular dystrophy,
and ECM remodeling (Bertrand et al., 2014; Calvo et al., 2013;
Ferna´ndez et al., 2006; Goetz et al., 2011; Grijalva et al., 2014;
Hagiwara et al., 2000; Minetti et al., 1998). We hypothesized
that impaired ECM remodeling in CAV1-deficient cells (Goetz
et al., 2011) might be caused by deficient YAP activity. To test
this, we transfected Cav1KO cells with either non-phosphorylat-
able YAP-5SA (able to increase YAP transcriptional output in
Cav1KO cells; see Figures 3G and 3H) or WT YAP. ECM remod-
eling was assessed by (1) collagen gel contraction assay and
(2) quantitative image analysis of collagen fiber organization by
second harmonic generation (SHG) microscopy (Figures 5A
and 5B). As expected, ECM remodeling activity was blunted in
Cav1KO MEFs. Interestingly, YAP-5SA overexpression restored
the ability of these cells to remodel the matrix, whereas WT YAP
was ineffective. Furthermore, we observed a clear correlation
between CAV1 expression and YAP nuclear localization in hu-
man cancer-associated fibroblasts (CAFs) from pancreatic tu-
mors (Figures 5C and 5D), and CAV1 silencing in these cells
induced YAP cytosolic retention (Figure 5D), supporting a major
role for a CAV1-YAP regulation in determining the activation
state of stromal cell populations in vivo. Based on these observa-
tions, we propose that CAV1 and YAP nucleate a signaling
pathway that drives ECM remodeling and stiffening.
CAV1 Is Required for YAP Activation in
Pancreatitis-Associated ADM
Pancreatitis causes tissue damage and desmoplasia, promoting
the development of ADM and potentially contributing to PDAC
onset and progression (Guerra et al., 2007). We chose pancrea-
titis as a model to study the potential contribution of CAV1-YAP
regulation in vivo, because YAP is required for pancreatitis-
induced ADM (Morvaridi et al., 2015) and CAV1 expression
is upregulated in pancreatic cancer and it is associated with
decreased survival (Chatterjee et al., 2015).
Mild and reversible acute pancreatitis was induced in WT and
Cav1KOmice by intraperitoneal administration of the cholecisto-
kinin receptor agonist caerulein (Niederau et al., 1985). 2 hr andFigure 4. The YAP Interactome Is Altered in Cav1KO MEFs
(A and B) Mass spectrometry analysis of YWHA proteins (A) and nuclear pore com
YAP in WT and Cav1KO MEFs treated with or without 1 mM CytD for 24 hr. The
Negative controls (first and third column) were performed in parallel by omitting
(C) siRNA library screening scheme for identifying YAP activity regulators.
(D) Plot of mean Z scores of the YAP nuclear-to-cytosolic ratio for each individua
(E) Mean Z score of the YAP nuclear-to-cytosolic ratio in WT and Cav1KO cell
below 2.5. n = 3.
(F) qRT-PCR of Ctgf and Ankrd1 in cells transfected with control or YWHAH siRN
cells grown on soft substrate. n = 5. Data are presented as means ± SEM. *p < 0
(G) Scheme of CAV1-YAP regulation.
See also Figures S4 and S5, Table S2, and Data S1.
1630 Cell Reports 25, 1622–1635, November 6, 20184 days after caerulein treatment, nuclear YAP expression was
significantly higher in WT preparations (Figures 6A and 6B).
This correlates with an increase in the areas presenting extensive
ADM and fibrosis, assessed by aSMA expression in pancreatic
stellate cells 4 days after treatment (Figures 6C, S6A, and
S6B). Taken together, these data suggest that CAV1 is required
for YAP activation in the context of caerulein-induced pancrea-
titis and that this activation correlates with increased ADM in
pancreatic tissue.
DISCUSSION
Our results identify CAV1 as an upstream regulator of YAP-
dependent adaptive programs, working through mechanisms
dependent on the control of actin dynamics. This CAV1-depen-
dent control of YAP activity relies, at least in part, on the revers-
ible phosphorylation of YAP, evidenced by the association of
blunted YAP activity in Cav1KO cells with increased YAP phos-
phorylation and its rescued by exogenous expression of non-
phosphorylatable YAP. We found no role for LATS1/2 in this
mechano-dependent negative regulation, observing no YAP
activity recovery either upon transient silencing of both kinases
or upon silencing of NF2. YAP might also be a substrate for
JNK and Abl (Codelia et al., 2014; Levy et al., 2008) or as-yet un-
identified kinases that could be responsible for YAP regulation.
Another possible explanation for increased YAP phosphorylation
in the absence of CAV1 is a protection of phosphorylated YAP
from dephosphorylation through interaction with 14-3-3 YWHA
proteins. This interpretation is supported by our interactome
profiling and systematic functional screening studies, which
showed increased interaction of YWHA proteins with YAP in
Cav1KO cells and specific rescue of YAP translocation upon
their siRNA depletion. YAP retention in the cytosol upon interac-
tion with YWHAH proteins led to deficient YAP transcriptional
activity in these cells. Furthermore, YWHAH proteins positively
control Yap expression (Figures S4G and 4F), adding a new level
of complexity to the control of YAP activity. Our studies also
identify several regulators of YAP nuclear translocation,
including nuclear pore components and proteins involved in
nucleocytosolic transport.
Changes in stromal stiffness and architecture can enhance
tumor aggressiveness, promote resistance to therapy, and favor
metastasis (Levental et al., 2009). During tumor progression,
CAFs surrounding the tumor may favor an increase in the stiff-
ness of the tumor mass. In CAFs, ECM stiffness itself is an acti-
vating cue, thus potentially enabling a mechanically drivenponents and nucelocytosolic transporters (B) that co-immunoprecipitate with
heatmap represents the relative number of counts per protein and condition.
the primary anti-YAP antibody. n = 5.
l siRNA in WT and Cav1KO MEFs.
s after siRNA transfection for those genes whose Z scores are above 2.5 or
As: WT and Cav1KO MEFs, WT cells treated for 24 hr with 1 mM CytD, and WT
.05 and **p < 0.01.
A B
C
D E
Figure 5. YAP Mediates the Effect of CAV1 in ECM Remodeling
(A and B) Collagen gel retraction induced by MEFs transfected with YAP-Flag or YAP(S5A)-FLAG.
(A) Cells were embedded in 3D collagen gels, and images were acquired 72 hr later to monitor gel retraction. Collagen organization was determined by second
harmonic generation (SHG) microscopy (black and white images). Mock represents mock transfection.
(B) Corresponding ImageJ quantification of gel contraction, measured as the fold change with respect to the contraction observed in mock-transfectedWT cells.
n = 3 experiments.
(C) Confocal immunofluorescence images of CAV1 and YAP in cancer-associated fibroblasts (CAFs) extracted from the stroma of human pancreatic tumors and
cultured in vitro. Nuclei were detected with Hoechst (blue). Symbols mark cells with low (*) or high (+) CAV1 levels.
(D) Plot of YAP nuclear-to-cytosolic ratio against CAV1 intensity for individual CAFs as in (C). N = 97.
(E) Quantification of YAP subcellular distribution (left) and CAV1 levels (right) in CAFs transfected with CAV1 siRNAs or controls. CAV1 and YAP were detected
by confocal immunofluorescence microscopy. A total of 4 independent experiments (n = 4) were analyzed (500 cells per experiment and condition) using
Columbus. See STAR Methods for details.
Data are presented as means ± SD in (B) and means ± SEM in (E); *p < 0.05, ***p < 0.005, and ****p < 0.0005.feedforward loop in which YAP nuclear translocation is neces-
sary for this activation (Calvo et al., 2013). CAV1 expression in
CAFs correlates with higher remodeling capacity and facilitates
tumor invasion (Goetz et al., 2011). Our results provide the first
evidence of a functional connection between these nodes. 3D
assays show that exogenous expression of a constitutively
active YAP mutant reverts the impairment of ECM remodeling
associated with CAV1 deficiency. This proposed CAV1-YAPregulation is therefore likely a significant driver of key events in
tumor progression.
Pancreatitis is characterized by immune cell infiltration, inter-
lobular and interacinar edema, and fibrosis and is a major risk
factor for the development of pancreatic cancer (Yadav and
Lowenfels, 2013). YAP contributes to acinar cell dedifferentiation
in ADM and prevents the regeneration of injured areas (Gruber
et al., 2016; Murakami et al., 2017). Furthermore, inflammationCell Reports 25, 1622–1635, November 6, 2018 1631
BA
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Figure 6. CAV1 Determines YAP Activation and
ADM in Caerulein-Induced Acute Pancreatitis
(A) Immunohistochemistry analysis of YAP expression in
pancreatic tissue of WT and Cav1KO mice 4 days after
caerulein treatment.
(B) Quantification of the percentage of the nuclear area
covered by YAP staining 2 hr and 4 days after caerulein
treatment. n = 8.
(C) Quantification of the percentage pancreatic area
showing extensive ADM after 4 days of chronic
pancreatitis in WT mice (n = 4) and Cav1KO mice (n = 3).
Data in (B) and (C) are presented as means ± SEM;
*p < 0.05, **p < 0.01. See also Figure S6.increases stiffening (Hidalgo, 2012), and the increased tissue
stiffness in caerulein-induced acute pancreatitis could explain
the differences in YAP activation between WT and Cav1KO
mice. Our results thus support an important role for CAV1-YAP
regulation in vivo and suggest a potential link between inflamma-
tion-induced stiffness and disease progression. These results
suggest the interesting possibility that CAV1-YAP regulation
could determine pancreatic cancer progression, since YAP is
required for the initial stages of PDAC development (Gruber
et al., 2016).
Our results demonstrate that CAV1 regulates YAP activity,
determining the mechanical response to changes in ECM rigidity
and other mechanical cues. CAV1-YAP regulation modulates
pathophysiological processes such as ECM remodeling and
the response to acute pancreatitis. These findings suggest
that this regulation could determine the onset and progression
of different physiological and pathological processes, such as
tumor development, through multiple mechanisms.
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Antibodies
Mouse monoclonal anti-YAP (63.7) Santa Cruz Biotechnology Cat# sc-101199, RRID: AB_1131430
Mouse monoclonal anti-TEF-1 (H-4) Santa Cruz Biotechnology Cat# sc-376113, RRID: AB_10988229
Rabbit monoclonal anti-CAV1 (D46G3) XP Cell Signaling Tecnology Cat# 3267S, RRID: AB_2275453
Rabbit monoclonal anti-14-3-3 h (D23B7) Cell Signaling Tecnology Cat# 5521S, RRID: AB_10829034
Monoclonal ANTI-FLAG M2 antibody Sigma-Aldrich Cat# F3165, RRID: AB_259529
Mouse monoclonal anti-glyceraldehyde-3-phosphate
dehydrogenase antibody
Millipore Cat# MAB374, RRID: AB_2107445
Rabbit polyclonal anti-Phospho-YAP (Ser127) Antibody Cell Signaling Technology Cat# 4911S, RRID: AB_2218913
Rabbit polyclonal anti-Anti-LATS1 Antibody Cell Signaling Technology Cat# 9153S, RRID: AB_2296754
Rabbit polyclonal anti-Anti-LATS1 Antibody Cell Signaling Technology Cat#13646
Rabbit polyclonal anti-Anti-H3 Histone Antibody Abcam Cat# ab1791, RRID: AB_302613
Rabbit polyclonal anti-RHO GDIalpha (A-20) antibody Santa Cruz Biotechnology Cat# sc-360, RRID: AB_2227516
Rabbit monoclonal anti-YAP (D8H1X) XP Cell Signaling Technology Cat# 14074, RRID: AB_2650491
Rabbit Anti-Human Actin, Smooth Muscle Epitope Specific
antibody
Thermo Fisher Scientific Cat# RB-9010-P0, RRID: AB_149755
Alexa Fluor 488 Goat Anti Mouse IgG (H+L) Molecular Probes Cat# A-11029, RRID: AB_138404
Alexa Fluor 546 Goat Anti Mouse IgM (m chain) Molecular Probes Cat# A-21045, RRID: AB_2535714
Alexa Fluor 546 Goat Anti Rabbit IgG (H+L) Molecular Probes Cat# A-11035, RRID: AB_143051
Alexa Fluor 488 Goat Anti Rabbit IgG (H+L) Molecular Probes Cat# A-11034, RRID: AB_2576217
Goat anti-Mouse IgG (H+L) Secondary Antibody, HRP Thermo Fisher Scientific Cat# 31430, RRID: AB_228307
Goat anti-Rabbit IgG (H+L) Secondary Antibody, HRP Thermo Fisher Scientific Cat# 31460, RRID: AB_228341
Bacterial and Virus Strains
N/A N/A N/A
Biological Samples
N/A N/A N/A
Chemicals, Peptides, and Recombinant Proteins
ROCK inhibitor Y27632 Sigma-Aldrich Y0503; CAS Number 129830-38-2
CytochalasinD Sigma-Aldrich C8273; CAS Number: 22144-77-0
Jasplakinolide Santa Cruz Biotechnology sc-202191; CAS 102396-24-7
Caerulein Sigma-Aldrich C9026; CAS Number: 17650-98-5
Critical Commercial Assays
Lipofectamine RNAiMAX Transfection Reagent Invitrogene Cat#10601435
Alexa Fluor 647 Phalloidin Invitrogene Cat# A22287, RRID:AB_2620155
Dual-Luciferase Reporter Assay System Promega Cat#E1910
RNAeasy micro kit QIAGEN Cat#74004
Omniscript RT kit QIAGEN Cat# 205111
Random primers Promega Cat#C1181
SYBR green Applied Biosystems Cat#4309155
G-Actin/F-actin In Vivo Assay Biochem Kit Cytoskeleton Cat#BK037
Deposited Data
RNaseq data This paper GEO: GSE120514
Mass spectrometry data Table S2 N/A
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Experimental Models: Cell Lines
WT and Cav1KO Mouse embryonic fibroblasts (MEF) Razani et al., 2001 N/A
WT and Cav1KO Neonatal Hepatocytes (mouse) Mayoral et al., 2010 N/A
MDA-MB-231 HTB-26 breast adenocarcinoma (human) ATCC Cat# HTB-26, RRID: CVCL_0062
HeLa CCL-2 ATCC Cat# CCL-2, RRID: CVCL_0030
HeLa Cav1–GFP Lukas Pelkmans laboratory N/A
Primary pancreatic cancer associated fibroblasts (PanCAF) Manuel Hidalgo Laboratory N/A
Experimental Models: Organisms/Strains
Mouse: Cav1KO C57BL/6 Drab et al., 2001 N/A
Oligonucleotides
siRNA targeting sequence: Cav1 #1:
GAGCUUCCUGAUUGAGAUU (sense sequence)
This paper N/A
ON-Target Plus Smart-pool siRNAs; see Table S3 Dharmacon N/A
Primers for qRT-PCR Table S4 N/A
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p2xFlag CMV2-YAP2 Oka et al., 2008 Addgene #19045
pCMV-flag YAP2 5SA Zhao et al., 2007 Addgene #27371
8xGTIIC-luciferase Dupont et al., 2011 Addgene #34615
pLVX-CMV-CherryFP-P2A-MetLuc This paper N/A
pLVX_shRNA2 Clontech Cat#632179
CMVCherryFPP2A Viral vectors Unit (CNIC) N/A
pMetLuc reporter Viral vectors Unit (CNIC) N/A
pEGFP–mDia1(DeltaN3) Ishizaki et al., 2001 N/A
pEGFP-RHO(V14) del Pozo et al., 1999 N/A
Software and Algorithms
qBase plus Biogazelle N/A
MATLAB (R2015a) MATLAB N/A
ImageJ National Institutes of Health https://imagej.nih.gov/ij/download.html
FibrilTool plug-in Boudaoud et al., 2014 https://media.nature.com/original/
nature-assets/nprot/journal/v9/n2/
extref/nprot.2014.024-S3.txt
Ingenuity Pathway Analysis software QIAGEN N/A
Enrichr Enrichr - Ma’ayan Laboratory -
Computational Systems Biology
http://amp.pharm.mssm.edu/Enrichr/
Columbus Image Data Storage and Analysis System PerkinElmer http://www.perkinelmer.com/es/
product/image-data-storage-and-
analysis-system-columbus
Search-Based Exploration of Expression Compendium (SEEK) Troyanskaya Functional
Genomics Laboratory at
Princeton University, 2014
http://seek.princeton.edu/
GraphPad Prism GraphPad Software https://www.graphpad.com/company/
Fisher exact test calculator Social Science Statistics web site http://www.socscistatistics.com/
tests/fisher/Default2.aspx
Other
pre-printed micropatterns CYTOO N/A
Fibronectin-coated 6-well plates for uniaxial stretching FlexCell Cat# UF-4001P
Flexcell FX-5000 Tension System FlexCell N/A
Protein G Sepharose 4 Fast Flow GE Healthcare Cat# GE17-0618-01
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
In vivo animal studies
Cav1KO C57BL/6 mice (Drab et al., 2001) were bred under specific pathogen-free conditions at the CNIC. Experiments were
performed with 8-12-week-old males (Cav1KO and age-matched control littermates). All animal protocols (PROEX 097/18) were
in accordance with Spanish animal protection law and were authorized by the corresponding local authority.
Cell culture
MEFs were isolated from WT and Cav1KO littermate mice, immortalized, and cultured as described (Razani et al., 2001).
Neonatal hepatocytes from WT and Cav1KO littermates were isolated, phenotyped (Mayoral et al., 2010), and kindly provided by
Dr. Martı´n-Sanz (IIBM Alberto Sols, Spain). The human MDA-MB-231 breast carcinoma and HeLa cell lines were obtained from
ATCC. HeLa cells expressing CAV1–GFP were kindly provided by Lukas Pelkmans (ETH, Z€urich, Switzerland). MEFs, hepatocytes
and HeLa cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) and MDA-MB231 cells were grown in DMEM/F-12
(GIBCO, Thermo Fisher Scientific [Waltham; Massachusetts, United States]); growth media were supplemented with 10% fetal
bovine serum (FBS; GIBCO, Thermo Fisher Scientific and GE Healthcare Life Science HyClone [Little Chalfont, United Kingdom])
and 100 mg/ml penicillin and streptomycin (GIBCO, Thermo Fisher Scientific). Primary pancreatic cancer associated fibroblasts
(PanCAF) were a gift fromManuel Hidalgo (Centro Nacional de InvestigacionesOncolo´gicas, Spain). PanCAFswere grown in Roswell
Park Memorial Institute medium (RPMI) supplemented with 20% FBS, 100 mg/ml penicillin and streptomycin, and 5% glutamine. All
cells were maintained in a humidified atmosphere at 37 C and 5% CO2.
METHOD DETAILS
Polyacrylamide matrices
Polyacrylamide gels with tuneable stiffness were prepared on glass coverslips as previously described (Tse and Engler, 2010). 3-ami-
nopropyltrimethoxysilane (Sigma-Aldrich [St. Louis, Missouri, United States]) was applied over the surface of a coverslip using a cot-
ton-tipped swab and another coverslip was treated with Sigmacote (Sigma-Aldrich). The coverslips were then washed thoroughly
with sterilized water and dried. Acrylamide/bis-acrylamide solutions were prepared using appropriate concentrations to obtain stiff
matrices (Young’s modulus 55 KPa) and soft matrices (200 Pa) as previously defined (Fischer et al., 2012). Polymerization initi-
ators (0.05% w/v ammonium persulfate and 0.0005% v/v N,N,N0,N0-tetramethylethylenediamine [TEMED], final concentrations)
were added to the bis-acrylamide mixture. A drop of this mixture was deposited on top of the silanized glass and covered with
the sigmacote-treated coverslip; 183 mL was deposited for round coverslips (40mm diameter) and 50 mL for square coverslips
(24x24mm). After polymerization, the upper coverslip was removed and the polyacrylamide surfacewas photo-activated by exposing
the sulfo-SANPAH crosslinker (Sigma-Aldrich) to UV light. Finally, the surface was coated with fibronectin (5 mg/ml) for 1 h at 37C.
Fibronectin was then removed and cells were seeded at low confluence. Experiments were performed 24h after seeding.
Micropatterns
Glass slides with pre-printed micropatterns were purchased from Cytoo (Grenoble, France). Designs for customized patterns with
specific grid sizes were described by Dr. Piccolo and colleagues (Dupont et al., 2011). Fibronectin coating was performed as spec-
ified by the supplier. Cells were plated, and 24 h later, fixed and stained following standard protocols.
Cell strain
24h after plating on fibronectin-coated 6-well plates (FlexCell [Burlington, North Carolina, United States]), cells were subjected
to uniaxial cyclic stretching (0.7Hz, 8%–9% amplitude) for 24h on a programmable Flexcell FX-5000TMTension System (FlexCell)
under standard culture conditions.
Reagents and transfections
The ON-TARGET plus SMARTpool siRNAs were purchased from Dharmacon (Table S3; Lafayette, Colorado, United States), siRNA
targeting human CAV1 was custom made (sense sequence: GAGCUUCCUGAUUGAGAUU. Cells were transfected with siRNAs
at 20pmol/1000 cells using Lipofectamine RNAiMAX (Invitrogene; Carlsbad, California, United States). Silencing was allowed to
proceed for 48h before terminating the experiment.
p2xFlag CMV2-YAP2 was a gift from Dr. Sudol (Addgene plasmid # 19045; Cambridge, Massachusetts, USA) (Oka et al., 2008).
pCMV-flag YAP2 5SA (Addgene plasmid # 27371) was a gift from Dr. Guan. 8xGTIIC-luciferase (Addgene plasmid # 34615) was a
gift from Dr. Piccolo. The lentiviral backbone for pLVX-CMV-CherryFP-P2A-MetLuc was derived from pLVX_shRNA2 (Clontech;e3 Cell Reports 25, 1622–1635.e1–e6, November 6, 2018
Mountain View, California, United States) and was provided by the CNIC Viral Vectors (VV) Unit. CMVCherryFPP2A was obtained
from pRRL_CMV_CherryFP_P2A (provided by the CNIC VV Unit and cloned into pLVX). The Metridia luciferase (secretable form)
was amplified from pMetLuc reporter (Clontech; also provided by the CNIC VVUnit) and cloned in-framewith the CherryFP-P2A pep-
tide. pEGFP–mDia1(DeltaN3) and pcDNA3-HA-RHO(V14) were as described (del Pozo et al., 1999; Ishizaki et al., 2001). All transient
transfections were by electroporation with 5 mg plasmid DNA and 35 mg UltraPure salmon sperm DNA solution (Sigma-Aldrich) at
350V and 550ohms for 10msec.
Drugs were added to cells 3h after plating, followed by incubation for a further 21h. The ROCK inhibitor Y27632 (Y0503) and
cytochalasinD (C8273) were from Sigma-Aldrich. Jasplakinolide (sc-202191) was from Santa Cruz Biotechnology (Dallas, Texas,
United States).
Antibodies
Monoclonal antibodies were sourced as follows: anti-YAP (sc-101199) and anti-TEF-1 (sc-376113) from Santa Cruz Biotechnology;
anti-CAV1 XP (#3267) and anti-YWHAH (14-3-3 h (D23B7); #5521) fromCell Signaling (Danvers, Massachusetts, United States); anti-
Flag M2 (F-3167) from Sigma-Aldrich; and anti-glyceraldehyde-3-phosphate dehydrogenase (MAB374) and anti-cortactin (p80/85,
clone 4F11) from Millipore (Burlington, Massachusetts, United States). Polyclonal antibodies to phospho-YAP (Ser127) (#9411),
LATS1 (#9153), and LATS2 (#13646) were from Cell Signaling; anti-Histone H3 (ab1791) was from Abcam (Cambridge, United
Kingdom); and anti-RHO GDI (sc-360) was from Santa Cruz Biotechnology. For immunohistochemistry, we used anti-YAP
(D8H1X) XP from Cell Signaling (#14074) and aSMA from Thermo Fisher Scientific (RB-9010-P0).
Immunofluorescence microscopy
For immunofluorescence procedures, cells were fixed in paraformaldehyde 4% (w/v) at 37C for 10 minutes, permeabilized, blocked
with 0.2% Triton X-100 in BSA 1% (w/v) for 10 min, and then immunostained with specific antibodies for 1h. Alexa647 phalloidin and
Alexa546- and Alexa488-labeled secondary antibodies were from Invitrogen. Images were acquired either on a Zeiss LSM700
confocal microscope or an Opera automated confocal microscope (PerkinElmer; Waltham, Massachusetts, United States).
Subcellular fractionation
For subcellular fractionation the cells were lysed (10 mM HEPES, pH 7.6, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.5 mM DTT,
100 mM phenylmethylsulfonyl fluoride, protease inhibitor cocktail [Roche], and 0.05% NP-40). Nuclear and cytoplasmic fractions
were separated by centrifugation. The cytosolic fraction was precipitated with acetone and nuclei were lysed (20 mM HEPES,
pH 7.6, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.75 mM spermidine, 0.15mM spermine,100 mM phenylmethylsulfonyl
fluoride, and protease inhibitor cocktail [Roche]) and centrifuged at 13000 rpm to remove the DNA. Both fractions were eluted
with sample buffer and analyzed by western blotting.
Immunoprecipitation
For immunoprecipitation, cells were lysed (50mM Tris-HCl at pH8, 100mM NaCl, 1% Triton X-100 [Sigma-Aldrich], 10% glycerol,
1mMMgCl2, 2mM PMSF, protease inhibitor cocktail [Roche]). Cell lysates were centrifuged for 10 min at 4C. Supernatants were
mixed with the specific antibody or control IgG for 2h, and protein G–agarose beads were added for a further 2h. Beads were washed
with washing buffer (50mM Tris-HCl pH7.5, 150mM NaCl, 1mM EDTA, 0.25% gelatin, 0.1% NP-40 [Sigma-Aldrich]) and processed
for mass spectrometry or western blotting.
Immunoblotting
For western blotting, immunoprecipitated proteins were eluted with sample buffer and analyzed by western blotting on nitrocellulose
membranes (Amersham Pharmacia Biotech, UK) with primary and secondary HRP-conjugated antibodies using standard protocols.
Proteins were detected by enhanced chemiluminescence (Amersham Life Sciences; Arlington Hts, Illinois, United States). Nuclear
and cytosolic subcellular fractions were prepared as described (Navarro-Le´rida et al., 2015).
Image analysis
YAP subcellular distribution was analyzed with the Columbus Image Data Storage and Analysis System (Perkin Elmer) or imageJ.
Nuclei were segmented using the Hoechst signal (Figure S4B). Mitotic and aberrant nuclei were then eliminated based on Hoechst
intensity and nuclear roundness and area. Cells located at the image borders were also eliminated. The cytosol was segmented
growing the nuclear segmentation (Figure S4C). The cytosolic ROI for cytosolic YAP intensity calculation was built as a 4 pixel
ring of cytoplasm grown radially from the segmented nuclear border (Figure S4C). Finally, the ratio between nuclear and cytosolic
YAP was calculated.
Second harmonic generation (SHG) imaging
Fibrillary collagen in non-fixed cell-embedded collagen gels was imaged using the SHG technique (Chen et al., 2012) with a Zeiss
LSM780 multiphoton microscope (Carl Zeiss Microscopy; Jena, Germany) fitted with a short pulse laser.Cell Reports 25, 1622–1635.e1–e6, November 6, 2018 e4
Luciferase assay
Luciferase assays to monitor TEAD transcriptional activity with the 8xGTIIC-luciferase reporter were as described (Mahoney et al.,
2005). Cells were transiently co-transfected with 8xGTIIC-luciferase (product: firefly luciferase) and pLVX-CMV-CherryFP-P2A-
MetLuc (product: Metridia luciferase [MelLuc], which is secreted to the medium). Luciferase activity was monitored with the Dual-
Luciferase Reporter Assay System (Promega; Madison, Wisconsin, United States) in an ORION II microplate luminometer (Titertek
Berthold; Bad Wildbad, Germany). Firefly luciferase was quantified in cell lysates by adding Luciferase Assay Reagent II (LARII), and
MetLuc was quantified in culture medium by adding Stop & Glo reagent. Firefly luciferase activity was normalized to MetLuc activity
to control for variability in transfection efficiency across samples.
Collagen contraction assay
Contraction assays to monitor matrix remodeling were as described (Goetz et al., 2011; Orimo et al., 2005). Briefly, 1.5 3 105 MEFs
were included in a collagen type I gel (PureCol, Sigma-Aldrich; 1.5mg/ml, 500 mL total volume) in an Ultra-Low Attachment 24-well
plate (Corning; Corning, New York, United States). After gel polymerization, normal culturemediumwas added, and collagen gel bor-
ders were detached from the border of the plate. Gels were cultured at 37 C, 5% CO2 for 48h. Gel contraction was monitored by
quantifying the gel surface area on photographs with ImageJ. The fold-change with respect to the contraction observed in a control
condition was calculated for each sample.
Acute pancreatitis induction
Acute pancreatitis was induced by caerulein treatment as described (Guerra et al., 2007). Before the experiment, mice were starved
for 12h with unrestricted access to drinking water. Acute pancreatitis was induced by 7 intraperitoneal injections of caerulein (Sigma-
Aldrich) dissolved in PBS; injectionswere given at 1-h intervals on 2 consecutive days at a dose of 50 mg caerulein /kg bodyweight per
injection. Control animals received injections of PBS only. At defined intervals, animals were sacrificed and the pancreas excised for
immunohistochemical analysis. Immunostained preparations were scanned with Hamamatsu Nanozoomer 2.0 RS (Hamamatsu,
Japan) and digitized with NDP.scan 2.5. Images were viewed and quantified with NDP.analyzer and NDP.view2 (Hamamatsu;
Hamamatsu City, Japan).
Real-time quantitative PCR
RNA was extracted from cell samples with the RNAeasy micro kit (QIAGEN; Hilden, Germany). For each sample, 1 mg RNA was
reverse transcribed using the Omniscript RT kit (QIAGEN) and random primers (Promega). qPCR was performed with SYBR green
(Applied Biosystems; Foster City, California, USA) Appropriate negative and positive controls were used (Hellemans et al., 2007).
Results were normalized to endogenous GAPDH and HPRT1 expression using qBase plus. Primer sequences were summarized
in Table S4.
RNA-Seq analysis
Next generation sequencing experiments were performed at the CNIC Genomics Unit. Total RNA was extracted as for qRT-PCR
(see above). RNA integrity was determined with an Agilent 2100 Bioanalyzer (Agilent Technologies; Santa Clara, California, United
States). Two RNA samples per condition were analyzed by single read (SR) sequencing in an Illumina HiSeq 2500 System (Illumina;
San Diego, California, United States). Data were analyzed in the CNIC Bioinformatics Unit. Enrichment analysis was conducted using
Ingenuity Pathway Analysis software (IPA, QIAGEN) and the Enrichr web tool.
Actin fiber organization analysis
Actin fiber organization was imaged and quantified inMATLAB (R2015a) and ImageJ (1.51a x64). Fiber order/parallelism in a ROI was
measured with a custommultiscale anisotropy analysis script based on the FibrilTool plug-in for ImageJ (Boudaoud et al., 2014); this
tool analyzes the structural information embodied by the eigenvalues and eigenvectors of a nematic tensor. Iterative performance of
this analysis in a collection of image patches of different sizes gives information about the organization of structures at multiple scales
and locations. The anisotropy value of each pixel in the original image is set to the mean anisotropy score obtained for each
processed patch containing the pixel. The patch collection is created by dividing the image into NxN nonoverlapping subimages,
with N˛f2iji = 0;1;2.gWf3iji = 0;1;2.g defining each iteration. The final multiscale anisotropy score is the mean of all the anisot-
ropy values of the pixels in the image. This measurement can be constrained to a specific area of interest by using only specific pixels
determined by prior segmentation, a useful way of avoiding interference from background or other structures that could bias the
results. In micropattern experiments, the inputs were cropped images of the cytoplasmic area of cells (241x261 pixels), avoiding
background and membranes as much as possible; no prior area restriction was defined, and the minimum size of patches was fixed
at 10x10 pixels.
Mass spectrometry analysis
Protein G–agarose beads bound to immunoprecipitated proteins were incubated at room temperature for 2h in a 60 mL volume of 2M
urea, 50 mM Tris-HCl pH 8.5, and 10 mM TCEP with gentle vortexing. Iodoacetamide (7 mL, 500 mM) was then added and the incu-
bation continued in the dark. After dilution to 0.5 M urea with ammonium bicarbonate, 3 mg of trypsin were added and samples weree5 Cell Reports 25, 1622–1635.e1–e6, November 6, 2018
incubated for 6-8 h at 37C. Samples were then acidified to 1% TFA, and the supernatants were desalted on C18 minispin columns
(The Nest Group; Southborough, MA, USA) and dried down for further analysis. Experiments were performed with 5 independent
replicates. Peptides were analyzed by LC-MS/MS using a C-18 reversed phase nano-column (75 mm I.D. x 50 cm, 2 mm
particle size, Acclaim PepMap RSLC, 100 C18; Thermo Fisher Scientific) in a continuous acetonitrile gradient consisting of
0%–32% B over 80 min, 50%–90% B over 3 min at 50C (A = 0.1% formic acid; B = 80% acetonitrile, 0.1% formic acid). Peptides
were eluted from the nanocolumn at a flow rate of 200 nL/min to an emitter nanospray needle for real-time ionization and peptide
fragmentation in a QExactive HF mass spectrometer (Thermo Fisher Scientific). The chromatographic run analyzed an enhanced
FT-resolution spectrum (70,000 resolution) followed by the MS/MS spectra from the 15 most intense parent ions. Dynamic exclusion
was set at 40 s. For peptide identification, all spectra were analyzed with Proteome Discoverer (version 2.1.0.81, Thermo Fisher Sci-
entific) using SEQUEST-HT (Thermo Fisher Scientific). For searching the Uniprot proteome database containing all sequences from
mouse and frequently observed contaminants (April 27, 2016; 48644 entries), the following parameters were selected: trypsin
digestion with 2 maximum missed cleavage sites; precursor and fragment mass tolerances of 2 Da and 0.02 Da, respectively; car-
bamidomethyl cysteine as a fixed modification; and methionine oxidation as a dynamic modification. Peptides were identified by the
probability ratio method (Martı´nez-Bartolome´ et al., 2008), and false discovery rate (FDR) was calculated using inverted databases
and the refined method (Navarro and Va´zquez, 2009) with an additional filtering for a precursor mass tolerance of 15 ppm (Bonzon-
Kulichenko et al., 2015). Proteins were quantified for each condition based on the number of scans/peptides identified at 1% FDR.
Image-based siRNA screening
The smart-pool siRNA library for selected YAP interactors detected by mass spectrometry was purchased from Dharmacon. Four
different sequences per each gene were used. SiRNAs were transfected by reverse transfection in 384-well plates. Cells were fixed
and stained for YAP detection 48h post transfection as described previously. Immunofluorescence images were acquired with an
Opera automated confocal microscope (PerkinElmer). Three replicates were performed, with four wells per siRNA in each replicate.
Two different ON-traget nontargeting siRNA controls were used. Transfection efficiency was validated by transfection with INCENP
siRNA, which promotes the appearance of multinucleated cells and cells with aberrant nuclei (Figure S4A). YAP nucleo:cytosolic ra-
tios were calculated using Columbus as described above (Image analysis section), and Z-scores were calculated as Z = (x – control
mean)/control standard deviation. The mean Z-score of the three replicates was calculated.
SEEK analysis
SEEK (http://seek.princeton.edu) is a computational coexpression gene search tool (Zhu et al., 2015). We queried this web tool with
the list of previously published YAP target genes (Dupont et al., 2011) and used all human expression datasets from tissue samples
and cell lines included in SEEK for coexpression analysis. The program gives a ranked list of genes ordered from the strongest pos-
itive correlation with the query to the weakest. With Enrichr (Chen et al., 2013; Kuleshov et al., 2016), we analyzed the enrichment in
KEGG annotated pathways and gene ontology (GO) terms of the 200 genes showing the highest positive coexpression with YAP
targets.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical details of experiments are reported in Figure Legends. Significance was evaluated by paired Student’s t test, using
GraphPad Prism. Differences were considered statistically significant at *p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.0005.
YAP-target gene enrichment on stiff versus soft substrates in the RNA-Seq analysis was compared by the Fisher exact test using
an online Fisher exact test calculator (http://www.socscistatistics.com/tests/fisher/Default2.aspx).
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GEO: GSE120514.Cell Reports 25, 1622–1635.e1–e6, November 6, 2018 e6
